Life-Altering Impact for Liver Cancer Patients From a Non-Invasive Treatment
At the time, the 62-year-old
At Memorial Cancer Institute, the newly installed Edison Histotripsy System gave her a groundbreaking alternative. Using high-intensity ultrasound waves, the FDA-approved technology liquefies tumors while leaving surrounding healthy tissue, blood vessels, and bile ducts intact.
"I wasn't scared at any moment, especially after the doctor explained the risk-benefit," said Brenda. "The risk was like the floor and the benefit was in the sky."
Brenda became one of the first patients in
"It's like an underwater tornado inside the tumor," said Dr. Omar Llaguna, a surgical oncologist with the Memorial Cancer Institute at Memorial Healthcare System. "The technology targets only the cancer cells, minimizing pain and recovery time."
In
Dr. Llaguna and his team are among the few specialists in
"We had the CT scan and the tumors were gone," said Brenda. "For me, it's a miracle."
Memorial Cancer Institute, part of Memorial Healthcare System, is one of the largest cancer centers in
To learn more, visit www.mhs.net/services/cancer.
View original content to download multimedia:https://www.prnewswire.com/news-releases/life-altering-impact-for-liver-cancer-patients-from-a-non-invasive-treatment-302737420.html
SOURCE Memorial Healthcare System
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts international conference on complex cardiac arrhythmias
- IMPERATIVE LOGISTICS GROUP DIVESTS MASTERPIECE INTERNATIONAL, REFINING ITS FOCUS ON MISSION CRITICAL DOMESTIC AND INTERNATIONAL SERVICES FOR SPECIALIZED SUPPLY CHAIN SOLUTIONS
- Wellness Workdays CEO and Founder Debra Wein Appointed to National Safety Council Wellbeing and Safety Advisory Board
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share